News & Insights

Stay up to date on PsychoGenics’ latest research, press releases, and industry developments in preclinical drug discovery. Combine our expertise with yours to spark the translational power of your next CNS breakthrough.

POSTER

Functional, Sensorimotor, and Cognitive Outcomes Following Unilateral MCAO in Rats

June 24, 2026
Read More
POSTER

Behavioral and pharmacological characterization of the isosorbide dinitrate model of headache in male and female rats

June 15, 2026
Read More
PUBLICATION

Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders.

August 14, 2007
Read More
PUBLICATION

Structure-based design leads to the identification of lithium mimetics that block mania-like effects in rodents. possible new GSK-3beta therapies for bipolar disorders.

July 12, 2007
Read More
PUBLICATION

Exploring neurocircuitries of the basal ganglia by intracerebral administration of selective neurotoxins.

June 30, 2007
Read More
PUBLICATION

Determination of the dopamine agonist rotigotine in microdialysates from the rat brain by microbore column liquid chromatography with electrochemical detection.

March 20, 2007
Read More
PUBLICATION

Mice with chronically elevated dopamine exhibit enhanced motivation, but not learning, for a food reward.

June 30, 2006
Read More
PUBLICATION

Monitoring brain chemical signals by microdialysis.

May 10, 2006
Read More
PUBLICATION

Discovery of novel hippocampal neurogenic agents by using an in vivo stable isotope labeling technique.

March 28, 2006
Read More
PUBLICATION

Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression.

June 30, 2005
Read More
PUBLICATION

Knock-in mouse models of Huntington’s disease.

May 15, 2005
Read More